Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New dosage strength and expanded indications approved for Climara

March 23, 1999

SD/01, a pegylated form of filgrastim with superior pharmacokinetics

March 23, 1999

Ergo Science intends to appeal FDA decision on Ergoset

March 23, 1999

Cholesterol biosynthesis inhibitors in the Zeneca pipeline

March 22, 1999

Further marketing authorizations granted in Europe for Muse

March 19, 1999

CPMP supports new labeling, new indication and new strength of Gonal-F

March 19, 1999

Licensing opportunity from Yeda: vanadyl ion carriers for the treatment of diabetes

March 19, 1999

Effects of raloxifene on coronary vasculature studied in vitro: results presented at ACC meeting

March 18, 1999

Steroid-piperazine compounds for bone disorders discovered at Chinese university

March 18, 1999

Selective beta3-adrenoceptor agonists patented by Asahi Chemical

March 18, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...